Startups
LimmaTech Biologics
https://lmtbio.comSelf-adjuvanting and multi-antigen vaccine technology platform.
Summary
Industry
Investors
Novo A/S Series A
Novo A/S Series A
Adjuvant Capital Series A
Repair Impact Fund Series A
AXA Investment Managers Series A
Tenmile Series A
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable